cbl-3: a new mammalian cbl family protein

Citation
Mm. Keane et al., cbl-3: a new mammalian cbl family protein, ONCOGENE, 18(22), 1999, pp. 3365-3375
Citations number
43
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
18
Issue
22
Year of publication
1999
Pages
3365 - 3375
Database
ISI
SICI code
0950-9232(19990603)18:22<3365:CANMCF>2.0.ZU;2-S
Abstract
We have cloned a new human gene, cbl-3, which encodes a protein with marked homology to the cbl family of proteins. The predicted protein encoded by t his gene retains the conserved phosphotyrosine binding domain (PTB) in the N-terminal and the zinc finger but is significantly shorter (MW 52.5 kDa) t han the other mammalian cbl proteins. The protein lacks the extensive proli ne rich domain and leucine zipper seen in c-cbl and cbl-b and structurally most resembles the C. elegans and Drosophila cbl proteins. The gene is ubiq uitously expressed with highest expression in the aerodigestive tract, pros tate, adrenal gland, and salivary gland. The protein is phosphorylated and recruited to the EGFR upon EGF stimulation and inhibits EGF stimulated MAP kinase activation. In comparison to the other mammalian cbl proteins (e.g. cbl-b), cbl-3 interacts with a restricted range of proteins containing Src Homology 3 regions, An alternatively spliced form of the cbl-3 protein was also identified which deletes a critical region of the PTB domain and which does not interact with the EGFR nor inhibit EGF stimulated MAP kinase acti vation. These data demonstrate that cbl-3, a novel mammalian cbl protein, i s a regulator of EGFR mediated signal transduction.